The FDA just approved a new ADHD medication that targets THREE neurotransmitters 馃憖 Centanafadine (Simtriyo) is the first norepinephrine, dopamine and serotonin reuptake inhibitor approved for ADHD. Here鈥檚 the pharmacology behind how it works. 馃拪 #ADHD #ADHDMedication #Centanafadine #Simtriyo #Pharmacist
1:10
The FDA just approved a new ADHD medication that targets THREE neurotransmitters 馃憖 Centanafadine (Simtriyo) is the first norepinephrine, dopamine and serotonin reuptake inhibitor approved for ADHD. Here鈥檚 the pharmacology behind how it works. 馃拪 #ADHD #ADHDMedication #Centanafadine #Simtriyo #Pharmacist
1.4M views1 month ago
TikTokmillennialrx
See more
Static thumbnail place holder